Ignite Creation Date:
2025-12-26 @ 11:09 AM
Ignite Modification Date:
2025-12-29 @ 4:50 AM
Study NCT ID:
NCT04857112
Status:
COMPLETED
Last Update Posted:
2025-09-09
First Post:
2021-04-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis
Sponsor:
Bausch Health Americas, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-29
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-08
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-19
First Submit QC Date:
None
Study First Post Date:
2021-04-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-12-15
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-09-05
Last Update Post Date:
2025-09-09
Last Update Post Date Type:
ESTIMATED